And some Med Advantage markets.
https://www.modernhealthcare.com/insurance/mh-elevance-health-medicare-advantage-plans-2026/#:~:text=Key%20Takeaways,offset%20their%20prescription%20drug%20costs.
5 replies (most recent on top)
Does anyone know if this will affect the RMSA and what we are able to spend it on?
I thought at first before reading the article that we were exiting the part D business entirely (which might be a good move for the long term). The article says exiting only some of the part D products, but moving out of the stand alone Medicare prescription market. With the disarray that Carelon is in, dropping the highest cost, highest utilization members’ segment might be a wise move. SLT will figure out a way to pull defeat out of the jaws of victory (like this team pretty much always does).
That's big news. What's that say about SLT when we have to find out these things from a site like this. Definitely, more RIFs to come.
And Norwood still gets to keep her high paying job???? What is wrong with this picture?
RIFS will never cease.